ULURU Inc. (NYSE AMEX: ULU) announced that clinical evidence utilizing Altrazeal™ Nanoflex Transforming Powder Dressing has been published in the respected peer-reviewed publication, International Wound Journal. The article, which is the first peer-review publication detailing clinical experience using Altrazeal™, was authored by a team of clinicians and scientists working at Southern Arizona Limb Salvage Alliance (”SALSA”) at the University of Arizona College of Medicine, located in Tucson, Arizona.
ALTRAZEAL
Transforming Powder Dressing with nanoflex technology
Sterile R • Sterile by Irradiation
PRODUCT DESCRIPTION:
The ALTRAZEAL Transforming Powder Dressing is a sterile dressing suitable for the covering and protection of exuding wounds such as burns, abrasions, skin graft donor sites, surgical wounds, and chronic, slow-healing wounds. The product consists of a sterile white powder in a single-use, sterile foil laminate pouch. The product is applied to an exuding wound by sprinkling the powder on the open wound. The particles then hydrate and aggregate to a final moisture content of approximately 65% by mass. The aggregated powder becomes a moist, flexible film over the surface of the open wound that provides an ideal moist wound environment supporting cellular function and tissue repair.
ALTRAZEAL is available in either 2-gram or 5-gram pouches. Each gram of the lyophilized powder consists of 84.8% poly-2-hydroxyethylmethacrylate (pHEMA), 14.9% poly-2-hydroxypropylmethacrylate (pHPMA), and 0.3% sodium deoxycholate.
Abrasions and lacerations
ALTRAZEAL may be used for: Exuding superficial acute wounds such as skin graft donor sites and second-degree burns (partial thickness burns with exudates, maximum 10% of body surface area) Surgical wounds, such as post-operative wounds or dermatological excisions (only as a primary dressing over wound, not to be used as replacement for sutures) Chronic, slow-healing wounds such as leg ulcers, pressure ulcers, and diabetic ulcers.
